Project HOPE and Merck Deliver Final Shipment of Pneumococcal Vaccine to Nicaragua to Complete National Vaccine Campaign

Project HOPE, a global health education and humanitarian assistance organization, in partnership with MSD, a leader in global health care (known as Merck in the United States and Canada), has delivered the final shipment of 200,000 doses of the vaccine PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) to Managua, Nicaragua as part of a national campaign to vaccinate vulnerable individuals against pneumococcal infections, a major cause of pneumonia.
Posted: April 19, 2013